Search

545 results:
Search results 211 until 220 of 545
211. [BIPS Project] Evaluation of the breast cancer mortality in the German Mammography Screening Program: Main study - 2nd part   The Mammography Screening Program (MSP) has been introduced nationwide in Germany since 2009. Following the introduction of the program, various options for investigating the effectiveness of this…  
212. Policy_Statement_engl_20131119.pdf   Policy Statement for the handling of conflicts of interest in BIPS research This statement aims to provide a basis for the discussion and management of conflicts of interest in order to ensure…  
213. anfahrt-bips-achterstrasse-eng.pdf   Leibniz-Institute for Prevention Research and Epidemiology – BIPS GmbH Contact & Travel Achterstr. 30 D-28359 Bremen Telefon: +49 (0)421 / 218-56 750 Telefax: +49 (0)421 / 218-56 941 By public…  
214. [BIPS Project] Spatial-temporal analysis of small-scale determinants of the COVID-19 pandemic   This research project aimed to provide detailed insights into area-specific key drivers of the COVID-19 pandemic and indicate to what extent educational level, household structure or average living…  
215. New blog series highlighting the research of Leibniz postdocs with Heide Busse from BIPS   One of the main goals of the Leibniz Postdoc Network is to raise the profile of postdocs working at the institutes of the Leibniz Association. While science & research during the pandemic have…  
216. [BIPS Project] Community-based integration of a digital mental health intervention in Pakistan   The project WellPak is conducted to alleviate the significant mental health burden in low-and middle-income countries. It is a collaboration between the Leibniz Institute of Prevention Research and…  
217. [BIPS Project] Drug utilisation study of eliglustat for the treatment of Gaucher disease type 1 in Europe using electronic healthcare records   Gaucher disease (GD) is a rare genetic disorder from the group of lysosomal storage disorders. It is characterized by the buildup of glucocerebroside in certain organs and tissues, particularly the…  
218. [BIPS Project] Non-interventional PASS to investigate the risk of mortality in MS-patients treated with alemtuzumab   Alemtuzumab (LEMTRADA®), a highly efficacious disease modifying therapy (HE-DMT), is a monoclonal antibody indicated for the treatment of relapsing remitting multiple sclerosis (RRMS) in patients…  
219. New Score for cardiovascular disease risk prediction in Europe released   New research from the European Society of Cardiology (ESC) to help predict the risk of cardiovascular disease (CVD), especially heart attack and stroke, has been published in the European Heart…  
220. Data Science Forum on Causal Reasoning   In this talk Prof. Dr. Vanessa Didelez will illustrate causal reasoning and methodology with two applications involving large databases: First we consider the question of predicting intervention…  
Search results 211 until 220 of 545